first-line therapy in advanced hcc
Published 6 years ago • 187 plays • Length 8:50Download video MP4
Download video MP3
Similar videos
-
4:30
regorafenib following first-line systemic therapy in hcc
-
24:30
controversies in hepatology: checkpoint inhibitors as first line therapy in hcc
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
5:19
lenvatinib remains standard of care for first-line therapy in advanced hepatocellular carcinoma
-
6:02
hcc: considerations in first-line use of sorafenib
-
0:57
the evolving landscape of first-line therapies in advanced hcc
-
8:01
emerging therapies in advanced hcc
-
1:58
dr liao on selecting between first-line monotherapy and combination approaches in hcc
-
7:29
understanding how best to sequence in advanced hcc
-
59:57
exploring new treatment options in hcc
-
5:48
second-line therapy in advanced hcc
-
6:39
emerging second-line therapies in hcc
-
8:28
debate: optimal first-line therapy in unresectable hcc? - mki followed by immunotherapy
-
58:25
molecular targeted therapies for advanced hcc
-
7:57
optimizing sequencing of therapies in hcc
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
1:10
sequencing therapies in the first and second line for patients with hcc
-
1:21:23
new options, emerging combinations in advanced hepatocellular carcinoma
-
24:30
reviewing the outcomes in hcc with 1st line immunotherapy: when is the right time to switch?